09 gennaio 2017 Radioterapia

First Cancer Patients in the World Treated with the Smart, New Accuray Radixact System

SUNNYVALE, Calif., Dec. 8, 2016 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that leading hospitals in Europe and the United States are now treating patients with the new Radixact™ Treatment Delivery System, fully integrated with the new Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. The first patient treatment in the world was administered at the University Hospital Brussels (UZ Brussel) in Belgium and in the United States at Froedtert & the Medical College of Wisconsin Froedtert Hospital in Milwaukee, Wisconsin, part of the Froedtert & MCW Cancer Network.

The Radixact System in Europe
The University Hospital Brussels (UZ Brussel) continues its legacy of innovation with the installation of the Radixact System, software, and treatment of the first patient worldwide. The smart new radiation therapy system represents the next generation in TomoTherapy® treatment delivery, significantly increasing treatment speed and ease of use. It enables clinicians to treat a wide range of cancer cases, from routine to complex, with precision and increased efficiency.

"We are proud and excited to be the first hospital in the world to offer the new Radixact treatment option to our patients here in Brussels. This advanced technology represents another step forward toward optimal cancer care and improved quality of life for patients," said Prof. Mark De Ridder, Head of the Radiation Oncology Department, University Hospital Brussels (UZ Brussel, Vrije Universiteit Brussel). "The first patient who underwent a Radixact procedure received radiation to treat a metastatic mass in the neck. We are now actively treating patients across a broad range of cases and all treatments have gone smoothly. The precision software is straightforward, the image quality on the system is improved and dose delivery is efficient."

Additionally, patients in France will have access to the Radixact System with its recent installation at the IUCT Oncopole – Institut Universitaire du Cancer de Toulouse in Toulouse, France. The hospital's clinical experts use the most current advances in cancer treatments to develop personalized programs which improve the quality of care they provide to patients.

The Radixact System in the United States
Multiple sites in the United States are now equipped with the Radixact System. Miami Cancer Institute, a part of Baptist Health South Florida, and Froedtert & MCW Cancer Network are the first to install the system.

Froedtert Hospital treated the first patient in the United States and is the only cancer program in the Midwest currently offering treatment with the advanced Radixact platform. Froedtert and MCW physicians selected this system because it expands cancer treatment capabilities to improve patients' outcomes and quality of life.

"For more than a decade, the Froedtert & MCW Cancer Network has been at the forefront of the evolution of image-guided and adaptive radiation therapy with the goal of providing more personalized treatments," said Christopher Schultz, MD, FACR, Medical College of Wisconsin Professor and Chairman of the Department of Radiation Oncology with the Froedtert & MCW Cancer Network. "The new Radixact™ platform tightly integrates the treatment planning function with the delivery of image-guided, highly conformal treatments and importantly, provides the tools to perform plan adaption when necessary." 

News

21/02/2017 News

Scopri il nuovo RayStation e partecipa ai webinar dedicati

Tecnologie Avanzate è lieta di comunicare che dopo il successo del lancio di RayCare a Roma, RaySearch Labs, che sin dal suo esordio ci ha abituati ad un costante susseguirsi di migliorie ed esclusive tecnologie, [...]

14/02/2017 News

Taiwan’s Chang Gung Memorial Hospital selects RayStation for proton therapy

Chang Gung Memorial Hospital, a leading teaching hospital in Kaohsiung, Taiwan, has chosen RayStation as the treatment planning system for use with its new Sumitomo proton therapy system. Established in 1976, the ho [...]

06/02/2017 News

RaySearch CEO and founder Johan Löf named Swedish entrepreneur of the year

On Wednesday 1 February, RaySearch CEO Johan Löf was honored as Sweden’s foremost entrepreneur in the national final of the EY Entrepreneur Of The Year competition, sponsored by Ernst & Young, at a ga [...]

Eventi

20gen2017 | Radioterapia

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

02mar2017 | Medicina nucleare

XIII Congresso Nazionale AIMN, Rimini 2-5 Marzo 2017

Tecnologie Avanzate sarà presente con uno spazio espositivo al XIII Congresso Nazionale AIMN che avrà luogo a Rimini presso il [...]

Video gallery